A Phase II trial evaluated the safety, efficacy and side-effect profile of three different dosing regimens of the albiglutide. This was a randomized, double-blind trial enrolling 356 subjects with ...

While the companies already share profits for lupus drug, BENLYSTA, this transaction will mean that GSK gains complete ownership of this drug, as well as diabetes drug, albiglutide, and coronary ...